Last 7 days
5.6%
Last 30 days
-2.1%
Last 90 days
4.8%
Trailing 12 Months
-25.9%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 108.0B | 18.4B | 9.81% | 7.15% | 45.81 | 5.86 | 7.84% | 18.25% |
ISRG | 89.4B | 6.2B | 12.38% | -15.32% | 67.62 | 14.37 | 8.97% | -22.43% |
BSX | 71.6B | 12.7B | 6.86% | 12.96% | 102.61 | 5.65 | 6.68% | -32.95% |
BDX | 70.1B | 19.0B | 7.04% | -3.24% | 43.54 | 3.69 | -0.43% | -8.78% |
EW | 50.3B | 5.4B | 3.61% | -29.72% | 33.07 | 9.35 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 14.55% | 4.57% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.6B | 847.1M | 7.86% | 25.46% | -5.3K | 12.54 | 13.32% | -137.89% |
GMED | 5.6B | 1.0B | -2.14% | -23.23% | 32.76 | 5.52 | 6.76% | 24.45% |
IRTC | 3.7B | 410.9M | 4.99% | -21.24% | -32.24 | 9.11 | 27.29% | -14.60% |
TNDM | 2.6B | 801.2M | 10.62% | -65.08% | -27.7 | 3.27 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
ATEC | 1.7B | 350.9M | 3.38% | 35.65% | -10.93 | 4.74 | 44.26% | -5.42% |
SILK | 1.5B | 138.6M | -18.17% | -5.23% | -27.28 | 10.83 | 36.62% | -10.44% |
AVNS | 1.4B | 820.0M | 5.46% | -11.22% | 27.4 | 1.69 | 10.13% | 701.59% |
CSII | 833.4M | 239.8M | 0.46% | -12.12% | -22.01 | 3.47 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 11.6% | 2,280 | 2,043 | 1,781 | 1,541 | 1,316 |
Gross Profit | 7.3% | 698 | 650 | 592 | 548 | 491 |
Operating Expenses | 10.7% | 741 | 669 | 572 | 493 | 368 |
S&GA Expenses | 11.2% | 608 | 547 | 468 | 383 | 303 |
R&D Expenses | 12.4% | 93.00 | 83.00 | 72.00 | 61.00 | 47.00 |
EBITDA | -65.5% | 45.00 | 130 | 151 | 159 | - |
EBITDA Margin | -69.1% | 0.02* | 0.06* | 0.08* | 0.10* | - |
Earnings Before Taxes | -175.6% | -123 | -44.97 | 24.00 | - | - |
EBT Margin | 10.4% | -0.05* | -0.06* | -0.03* | 0.02* | - |
Interest Expenses | -226.3% | -66.37 | 53.00 | 32.00 | 15.00 | 2.00 |
Net Income | -91.3% | -74.29 | -38.83 | 5.00 | 41.00 | 103 |
Net Income Margin | -71.4% | -0.03* | -0.02* | 0.00* | 0.03* | - |
Free Cahsflow | -122.2% | -152 | -68.59 | 12.00 | 137 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 1.5% | 4,516 | 4,450 | 4,590 | 4,747 | 1,881 |
Current Assets | 3.0% | 1,235 | 1,199 | 1,190 | 1,174 | 1,030 |
Cash Equivalents | -14.4% | 209 | 244 | 256 | 329 | 553 |
Inventory | 11.3% | 696 | 625 | 583 | 536 | 290 |
Net PPE | -3.1% | 636 | 656 | 668 | 674 | 468 |
Goodwill | 5.8% | 1,449 | 1,370 | 1,421 | 1,527 | 43.00 |
Current Liabilities | 1.1% | 495 | 489 | 486 | 494 | 201 |
LT Debt, Current | 21.8% | 30.00 | 24.00 | 19.00 | 14.00 | - |
LT Debt, Non Current | -0.4% | 1,630 | 1,636 | 1,642 | - | - |
Shareholder's Equity | 3.8% | 2,090 | 2,013 | 2,086 | 2,179 | 1,616 |
Retained Earnings | -1.8% | 838 | 853 | 866 | 874 | 912 |
Additional Paid-In Capital | 0.6% | 1,331 | 1,323 | 1,310 | 1,306 | 721 |
Accumulated Depreciation | - | 437 | - | - | - | - |
Shares Outstanding | 0.3% | 24.00 | 24.00 | 24.00 | 21.00 | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -379.8% | -62.13 | 22.00 | 99.00 | 215 | 268 |
Share Based Compensation | -1.8% | 36.00 | 37.00 | 34.00 | 33.00 | 27.00 |
Cashflow From Investing | 0.5% | -1,909 | -1,918 | -1,926 | -1,939 | -90.69 |
Cashflow From Financing | 0.3% | 1,637 | 1,632 | 1,631 | 1,635 | -16.87 |
Buy Backs | 30.6% | 11.00 | 8.00 | - | - | - |
68.5%
49.2%
29.2%
Y-axis is the maximum loss one would have experienced if ICU Medical was unfortunately bought at previous high price.
10.9%
7.0%
-8.1%
-6.5%
FIve years rolling returns for ICU Medical.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.68 | 55,302 | 2,020,780 | 0.02% |
2023-03-17 | American Portfolios Advisors | unchanged | - | -690 | 7,530 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -28.89 | -679,555 | 1,969,440 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -0.96 | 6,000 | 177,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -3.14 | 7,424 | 578,424 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | unchanged | - | -370 | 630 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 21,000 | 477,000 | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -98,000 | - | -% |
2023-02-21 | KB FINANCIAL PARTNERS, LLC | reduced | -20.37 | -1,000 | 7,000 | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 11.25 | 2,411,850 | 17,181,800 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 10.1% | 2,423,228 | SC 13G/A | |
Feb 10, 2023 | janus henderson group plc | 10.7% | 2,557,226 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.77% | 2,104,172 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 9.87% | 2,366,386 | SC 13G | |
Jan 31, 2023 | blackrock inc. | 7.5% | 1,787,807 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 12.8% | 2,725,540 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.18% | 1,950,253 | SC 13G/A | |
Feb 10, 2022 | janus henderson group plc | 10.8% | 2,294,880 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.9% | 1,686,855 | SC 13G/A | |
Jan 12, 2022 | smiths group international holdings ltd | 10.5% | 2,500,000 | SC 13D |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 95.70 -41.99% | 161.38 -2.17% | 313.85 90.26% | 586.11 255.30% | 985.35 497.33% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 15, 2023 | S-8 | Employee Benefits Plan | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | S-3ASR | S-3ASR | |
Feb 27, 2023 | 8-K | Current Report | |
Feb 27, 2023 | 10-K | Annual Report | |
Feb 14, 2023 | SC 13G/A | Major Ownership Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-08 | Woolson Daniel | sold (taxes) | -139,616 | 156 | -894 | vp, gm-infusion capital |
2023-03-08 | Bonnell Brian Michael | sold (taxes) | -181,626 | 156 | -1,163 | chief financial officer |
2023-03-08 | Voigtlander Christian B. | acquired | - | - | 2,209 | chief operating officer |
2023-03-08 | Voigtlander Christian B. | sold (taxes) | -181,626 | 156 | -1,163 | chief operating officer |
2023-03-08 | Jain Vivek | sold (taxes) | -207,550 | 156 | -1,329 | chairman and ceo |
2023-03-08 | Woolson Daniel | acquired | - | - | 2,020 | vp, gm-infusion capital |
2023-03-08 | Sanzone Virginia Ruth | sold (taxes) | -186,779 | 156 | -1,196 | vp, general counsel |
2023-03-08 | Sanzone Virginia Ruth | acquired | - | - | 2,272 | vp, general counsel |
2023-03-08 | Jain Vivek | acquired | - | - | 2,525 | chairman and ceo |
2023-03-08 | Bonnell Brian Michael | acquired | - | - | 2,209 | chief financial officer |
Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
REVENUES: | |||
Revenues | $ 2,279,997 | $ 1,316,308 | $ 1,271,004 |
Cost of Goods Sold | 1,582,236 | 824,818 | 809,507 |
Gross profit | 697,761 | 491,490 | 461,497 |
OPERATING EXPENSES: | |||
Selling, general and administrative | 608,345 | 302,583 | 283,953 |
Research and development | 92,984 | 47,498 | 42,948 |
Restructuring, strategic transaction and integration expenses | 71,421 | 18,037 | 28,409 |
Change in fair value of contingent earn-out | (32,091) | 0 | 9,000 |
Contractsettlements | 0 | 127 | (975) |
Total operating expenses | 740,659 | 368,245 | 363,335 |
Income from operations | (42,898) | 123,245 | 98,162 |
Interest Income (Expense), Net | (66,375) | 1,982 | 1,924 |
OTHER INCOME,NET | (5,136) | (2,041) | (2,592) |
Income before income taxes | (114,409) | 123,186 | 97,494 |
Provision for income taxes | 40,123 | (20,051) | (10,624) |
Net Income | $ (74,286) | $ 103,135 | $ 86,870 |
Basic | $ (3.11) | $ 4.86 | $ 4.16 |
Diluted | $ (3.11) | $ 4.74 | $ 4.02 |
WEIGHTED AVERAGE NUMBER OF SHARES | |||
Basic (in shares) | 23,868 | 21,206 | 20,907 |
Diluted (in shares) | 23,868 | 21,781 | 21,591 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 208,784 | $ 552,827 |
Short-term investment securities | 4,224 | 14,420 |
TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES | 213,008 | 567,247 |
Accounts receivable, net of allowance for doubtful accounts of $8,530 at December 31, 2022 and $7,038 at December 31, 2021 | 221,719 | 105,894 |
Inventories | 696,009 | 290,235 |
Prepaid income taxes | 15,528 | 19,586 |
Prepaid expenses and other current assets | 88,932 | 46,847 |
Total current assets | 1,235,196 | 1,029,809 |
PROPERTY, PLANT AND EQUIPMENT, net | 636,113 | 468,365 |
Operating Lease, Right-of-Use Assets | 74,864 | 39,847 |
Long-term Investment Securities | 516 | 4,620 |
GOODWILL | 1,449,258 | 43,439 |
INTANGIBLE ASSETS, net | 982,766 | 188,311 |
Deferred Income Tax Assets, Net | 31,466 | 42,604 |
Other Assets | 105,462 | 63,743 |
TOTAL ASSETS | 4,515,641 | 1,880,738 |
CURRENT LIABILITIES: | ||
Accounts payable | 215,902 | 81,128 |
Accrued liabilities | 242,769 | 118,195 |
Long-Term Debt, Current Maturities | 29,688 | 0 |
Accrued Income Taxes, Current | 6,200 | 1,454 |
Total current liabilities | 494,559 | 200,777 |
Contingent earn-out liability, Noncurrent | 25,572 | 2,589 |
Long-Term Debt, Noncurrent | 1,623,675 | 0 |
Other long-term Liabilities | 114,104 | 41,830 |
Deferred Income Tax Liabilities, Net | 126,007 | 1,490 |
Accrued Income Taxes, Noncurrent | 41,796 | 18,021 |
COMMITMENTS AND CONTINGENCIES | 0 | 0 |
STOCKHOLDERS' EQUITY: | ||
Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none | 0 | 0 |
Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,995 and 21,280 shares at December 31, 2022 and 2021, respectively, and outstanding 23,993 and 21,280 shares at December 31, 2022 and 2021, respectively. | 2,399 | 2,128 |
Additional paid-in capital | 1,331,249 | 721,412 |
Treasury Stock, Value | (243) | (27) |
Retained earnings | 837,501 | 911,787 |
Accumulated other comprehensive loss | (80,978) | (19,269) |
Total stockholders' equity | 2,089,928 | 1,616,031 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 4,515,641 | $ 1,880,738 |